Product Details
NAROPIN .5% 30mL VL 25BX NVP
Manufacturer: Fresenius Kabi
MFG#: 63323-0286-95
NDC: 63323-0286-95
PID: 417763
25/BX
$ *.**
Limited QuantitiesAdditional Information
| Product Name | Naropin 0.5% 30 mL VL 25Bx NVP |
| Application | Local Anesthetic |
| Generic Drug Name | Ropivacaine HCl, Preservative-Free |
| Mechanism of Action | Blocks sodium ion channels in nerve cells, preventing nerve impulse propagation. |
| Strength | 0.5%, 5 mg/mL |
| Type | Parenteral Solution |
| Volume | 30 mL |
| Onset of Action | 10-25 minutes depending on the site of administration. |
| Duration of Action | Approximately 2-6 hours for sensory blockade, varying by dose and site of administration. |
| Pharmacokinetics | Metabolized primarily by the liver, with renal excretion of metabolites. |
| Precautions | Avoid intravascular injection; monitor for systemic toxicity. |
| Adverse Reactions | Hypotension, bradycardia, nausea, dizziness, and rare central nervous system effects. |
| Packaging | Box of 25 single-use sterile ampules, preservative-free. |
| Storage Conditions | Store at room temperature (20-25°C), away from light and heat. |
| Indications | Surgical anesthesia, epidural anesthesia, labor pain management, and peripheral nerve block. |
Description
Naropin 0.5% (Ropivacaine Hydrochloride) is a long-acting local anesthetic solution used for surgical anesthesia and acute pain management. Each 30 mL vial contains 0.5% Ropivacaine, a member of the amide group of local anesthetics. Its primary mechanism involves blocking sodium ion channels in nerve cells, thereby inhibiting the propagation of nerve impulses.
The product is packaged in a box containing 25 sterile 30 mL vials, designed for single use to ensure safety and sterility. Being preservative-free, Naropin 0.5% minimizes the risk of allergic or adverse reactions related to additives. The formulation is particularly suited for situations where prolonged pain relief is required, including epidural anesthesia for surgeries, labor pain, and peripheral nerve blocks.
Naropin demonstrates a favorable pharmacological profile, including reduced cardiotoxicity and neurotoxicity compared to other local anesthetics like bupivacaine. The gradual onset of action and selective sensory nerve blockade make it a preferred choice in many clinical settings. The product is suitable for both inpatient and outpatient applications.
Frequently Asked Questions (FAQs)
The cost of NAROPIN .5% 30mL VL 25BX NVP is $$0.00
NAROPIN .5% 30mL VL 25BX NVP is manufactured by Fresenius Kabi.
You can purchase NAROPIN .5% 30mL VL 25BX NVP on our website at https://supplies.pipelinemedical.com/product/detail/naropin-5-30ml-vl-25bx-nvp-417763